Abstract
Coccidioidomycosis or the San Joaquin Valley fever is a granulomatous disease caused by the soil-dwelling dimorphic fungus Coccidioides immitis or Coccidioides posadasii. Ocular involvement typically occurs secondary to dissemination and is considered rare. The uvea is the most common site of intraocular disease. Coccidioidal uveitis should be considered in any patient with apparent idiopathic, granulomatous iridocyclitis, or choroiditis who has lived or traveled through endemic areas, including Arizona, New Mexico, west Texas, parts of Central America, Argentina, northwest Mexico, and the San Joaquin Valley in California. Skin and serologic testing confirm exposure to Coccidioidal antigen, but tissue biopsy is necessary for definitive diagnosis. Prompt recognition and treatment with systemic and local antifungal therapy is critical to save life, the eye, and potentially vision. Amphotericin B has proven efficacy but is limited by toxic adverse effects. Systemic and intravitreal azole therapy are efficacious against coccidioidomycosis. Oral azole therapy may be used primarily for less severe disease and for maintenance therapy. Without timely, appropriate treatment, many eyes will progress to requiring enucleation.
This is a preview of subscription content, log in via an institution.
Suggested Reading
Ampel NM. Coccidioidomycosis. In: Fauci AS, Braunweld E, Kasper DL, editors. Harrison’s Principles of Internal Medicine. New York: McGraw-Hill Book Company; 2008. p. 1247–9.
Ampel NM. What’s behind the increasing rates of coccidioidomycosis in Arizona and California? Curr Inf Dis Rep. 2010;12:211–6.
Assi MA, Binnicker MJ, Wengenack NL, et al. Disseminated coccidioidomycosis in a liver transplant recipient with negative serology: use of polymerase chain reaction. Liver Transpl. 2006;12(8):1290–2.
Bell R, Font RL. Granulomatous anterior uveitis caused by Coccidioides immitis. Am J Ophthalmol. 1972;74(1):93–8.
Binnicker MJ, Buckwalter SP, Eisberner JJ, et al. Detection of Coccidioides species in clinical specimens by real-time PCR. J Clin Microbiol. 2007;45(1):173–8.
Blair JE. State-of-the-art treatment of coccidioidomycosis: skin and soft-tissue infections. Ann NY Acad Sci. 2007;1111:411–21.
Blumenkranz MS, Stevens DA. Endogenous coccidioidal endophthalmitis. Ophthalmology. 1980;87(10):974–84.
Bouza E, Dreyer JS, Hewitt WL. Coccidioidal meningitis. An analysis of thirty-one cases and review of the literature. Medicine (Baltimore). 1981;60:139–72.
Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills MD, Grand MG. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol. 2005;139:135–40.
Catanzaro A, Galgiani JN, Levine BE, et al. Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group. Am J Med. 1995;98:249–56.
Centers for Disease Control and Prevention (CDC). Increase in Coccidioidomycosis – California, 2000–2007. MMWR Morb Mortal Weekly Rep. 2009;58:105–9.
Cheng ML, Leibowitz M, Ha E. Coccidioidal endophthalmitis in immunocompetent person, California, USA. Emerg Infect Dis. 2012;18(6):1015–6.
Cordeiro RA, Brilhante RS, Rocha MF, et al. In vitro activities of caspofungin, amphotericin B and azoles against Coccidiodes posadasii strains from Northeast Brazil. Mycopathologia. 2006;161:21–6.
Crum NF, Lederman ER, Stafford CM, et al. Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and current controversies. Medicine (Baltimore). 2004;83(3):149–75.
Crum-Cianflone NF. Voriconazole in combination with amphotericin B for salvage therapy of coccidioidomycosis. Infect Dis Clin Pract. 2007;15:265–8.
Cunningham ETJ, Seiff SR, Berger TG, Lizotte PE, Howes ELJ, Horton JC. Intraocular coccidioidomycosis diagnosed by skin biopsy. Arch Ophthalmol. 1998;116(5):674–7.
Dewsnup DH, Galgiani JN, Graybill JR, et al. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? Ann Intern Med. 1996;124:305–10.
Fish DG, Ampel NM, Galgiani JN, et al. Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine (Baltimore). 1990;69:384–91.
Foos RY, Zakka KA. Coccidioidomycosis. In: Pepose JS, Holland GH, Wilhelmus KR, editors. Ocular infection and immunity. St. Louis: Mosby; 1996. p. 1430–6.
Fusaro RM, Bansal S, Records RE. Some unusual periorbital dermatomes. Ann Ophthalmol. 1998;30:391–3.
Gabrielian A, Hariprasad SM. New onset of bilateral multifocal coccidioioidomycosal choroiditis in a patient on oral fluconazole. Can J Ophthalmol. 2010;45:419–20.
Galgani JN. Coccidioidomycosis: changes in clinical expression, serological diagnosis, and therapeutic options. Clin Inf Dis. 2006;42:S100–5.
Galgiani JN, Cantazaro A, Cloud GA, et al. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. Ann Intern Med. 2000;133:676–86.
Granoff DM, Libke RD. Coccidioidomycosis. In: Feigin RD, Cherry JD, editors. Textbook of pediatric infectious diseases. Philadelphia: WB Saunders; 1981. p. 1488–500.
Hagele AJ, Evans DJ, Larwood TR. Primary endophthalmic coccidioidomycosis: report of a case of exogenous primary coccidioidomycosis of the eye diagnosed prior to enucleation. In: Aiello L, editor. Coccidioidomycosis: Papers from the Second Symposium. Tucson: University of Arizona Press; 1967. p. 37–9.
Haque AK, McGinnis MR. Fungal Infections. In: Tomashefski JF Jr, Cagle PT, Farver CF, editors. Dail and Hammar’s Pulmonary Pathology. New York: Springer; 2008. p. 349–425.
Hirschmann JV. The early history of coccidioidomycosis: 1892-1945. Clin Infect Dis. 2007;44:1202–7.
Johnson RH, Einstein HE. Coccidioidal meningitis. Clin Inf Dis. 2006;42:103–7.
Lamer L, Paquin F, Lorange G, et al. Macular coccidioidomycosis. Can J Ophthalmol. 1982;17(3):121–3.
Levitt JM. Ocular manifestations in coccidioidomycosis. Am J Ophthalmol. 1948;31:1626–8.
Luttrull JK, Wan WL, Kubak BM, et al. Treatment of ocular fungal infections with oral fluconazole. Am J Ophthalmol. 1995;119:477–81.
Maguire LJ, Campbell RJ, Edson RS. Coccidioidomycosis with necrotizing granulomatous conjunctivitis. Cornea. 1994;13:539–42.
Mark AS, Blake P, Atlas SW, et al. Gd-DTPA enhancement of the cisternal portion of the oculomotor nerve on MR imaging. Am J Neuroradiol. 1992;13:1463–70.
Masannat FY, Ampel NM. Coccidioidomycosis in patients with HIV-1 infection in the era of potent antiretroviral therapy. Clin Infect Dis. 2010;50:1–7.
Mathisen G, Shelub A, Truong J. Coccidioidal meningitis: clinical presentation and management in the fluconazole era. Medicine (Baltimore). 2010;89:251–84.
Mondino KM, Holland GN, Glasgow BJ. Retinal seeding from anterior segment coccidioidomycosis after vitrectomy. Br J Ophthalmol. 2007;91:837–8.
Moorthy RS, Rao NA, Sidikaro Y, Foos RY. Coccidioidomycosis iridocyclitis. Ophthalmology. 1994;101(12):1923–8.
O’Day DM, Foulds G, Williams TE, et al. Ocular uptake of fluconazole following oral administration. Arch Ophthalmol. 1990;108:1006–8.
Oldgfield ECIII, Bone WD, Martin CR, et al. Prediction of relapse after treatment of coccidioidomycosis. Clin Infect Dis. 1997;25:1205–10.
Parish JM, Blair JE. Mayo Clin Proc. 2008;83(3):343–8.
Pettit TH, Learn RN, Foos RY. Intraocular coccidioidomycosis. Arch Ophthalmol. 1967;77:655–61.
Proia LA, Tenorio AR. Successful use of voriconazole for treatment of Coccidioides meningitis. Antimicrob Agents Chemother. 2004;48:2341.
Rixford E, Gilchrist TC. Two cases of protozoan (coccidioidal) infection of the skin and other organs. Johns Hopkins Hosp Rep. 1896;I:209–68.
Rodenbiker HT, Ganley JP. Ocular coccidioidomycosis. Surv Ophthalmol. 1980;24(5):263–90.
Rodenbiker HT, Ganley JP, Galgiani JN, Axline SG. Prevalence of chorioretinal scars associated with coccidioidomycosis. Arch Ophthalmol. 1981;99(1):71–5.
Stevens DA. Coccidioidomycosis. N Engl J Med. 1995;332:1077–82.
Tamesis RR. Coccidioidomycosis. In: Foster CS, Vitale AT, editors. Diagnosis and treatment of uveitis. New Delhi: Jaypee Brothers Medical Publishers; 2013. p. 526–30.
Tsang CA, Tabnak F, Vugia DJ, Benedict K, Chiller T, Park BJ. Increase in reported coccidioidomycosis–United States, 1998–2011. MMWR Morb Mortal Weekly Rep. 2013;62(12):217–21.
Vasconcelos-Santos DV, Lim JI, Rao NA. Chronic Coccidioidomycosis Endophthalmitis without concomitant systemic involvement: a clinicopathological case report. Ophthalmology. 2010;117:1839–42.
Ventocilla M. Ocular Coccidioidomycosis. Medscape, 28 Jan 2015. Web, 25 Oct 2015. http://emedicine.medscape.com/article/1204191-overview.
Vucicevic D, Blair JE, Binnicker MJ, et al. The utility of Coccidioides polymerase chain reaction testing in the clinical setting. Mycopathologia. 2010;170(5):345–51.
Warlick MA, Quan SF, Sobonya RE. Rapid diagnosis of pulmonary coccidioidomycosis. Cytologic v potassium hydroxide preparations. Arch Intern Med. 1983;143(4):723–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer (India) Pvt. Ltd.
About this entry
Cite this entry
Jonna, G., Agarwal, A. (2018). Coccidioidomycosis. In: Gupta, V., Nguyen, Q., LeHoang, P., Herbort Jr., C. (eds) The Uveitis Atlas. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2506-5_38-1
Download citation
DOI: https://doi.org/10.1007/978-81-322-2506-5_38-1
Received:
Accepted:
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-2506-5
Online ISBN: 978-81-322-2506-5
eBook Packages: Springer Reference MedicineReference Module Medicine